Ads
related to: drugs, brain development
Search results
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive via Yahoo Finance· 4 days agoLilly executives said that, later in the trial, they were able to better identify asymptomatic cases...
Alzheon secures $100m to advance Alzheimer’s disease treatment
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe development comes after the company raised $50m in a Series D round in 2022. The...patients. The...
New Scientific Article Published on Positive Clinical Results with Painless ACD440 Against...
Digital Journal· 1 day agoThe article, titled Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double-blind, placebo-controlled, crossover study.
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 4 days agoWhy it matters: The pair of 11-0 votes could pave the way for the antibody to become the second drug of its kind to win Food and Drug Administration...
Federal policy changes would hamstring Pennsylvania’s economy and hurt patients | Opinion
The Patriot-News· 2 days agoBefore 1980, the federal government held all the patents stemming from federally funded research.
Health care's biggest wild card
Axios· 3 hours agoWhen I've asked CEOs what they see as the wild card that will shape health care's future, almost all of them have mentioned emerging technology,...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 13 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
The Potential Benefits and Dangers of Rewiring the Brain
Mercola· 6 days agoThe panel includes neuroscientists Takao Hensch and John Krakauer, as well as entrepreneur Brett Wingeier, co-founder and CEO of Magnus Medical. This capacity could potentially heal depression ...
Lilly Alzheimer's drug gets unanimous backing from FDA advisory panel
New Hampshire Union Leader· 4 days agoOutside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits...
Lilly Alzheimer's drug gets unanimous backing from FDA advisory panel
Reuters via Yahoo News· 4 days ago(Reuters) -Outside advisers to the U.S. Food and Drug Administration on Monday voted unanimously...
